Stephanie B. Seminara, MD
3 registered trials on this site, 1 active. This page lists the trials this organization is registered as lead sponsor of, for the compounds covered on PeptideBlog.net. It is a registry listing, not an assessment of the company or its products.
Compounds covered
Registered trials
| Trial | Compound | Phase | Status | Sponsor | Enrolled | Primary completion | Registry updated |
|---|---|---|---|---|---|---|---|
| Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism NCT04648969 | Kisspeptin-10 | Phase 2 | Completed | Stephanie B. Seminara, MD | 18 | Aug 31, 2025 | Aug 26, 2026 |
| Kisspeptin Administration Subcutaneously to Patients With IHH NCT05896293 | Kisspeptin-10 | Phase 2 | Recruiting | Stephanie B. Seminara, MD | 36 | May 2028 | Jul 13, 2026 |
| Kisspeptin Administration Subcutaneously to Patients With Reproductive Disorders NCT05633966 | Kisspeptin-10 | Phase 1 | Completed | Stephanie B. Seminara, MD | 13 | Aug 31, 2025 | Oct 3, 2025 |
Data: ClinicalTrials.gov, U.S. National Library of Medicine. See the full trial tracker.
